The data is big,please wait a moment......
| EWAS ID | KEGG ID | Class | Disease/Phenotype [sample size n] |
Sample groups (case/control, trait, cell type etc.) |
KEGG Pathway Name | Pathway Gene Number | Gene Number Annotated In The KEGG Pathway | Pvalue | |
| Group1 [sample size n] |
Group2 [sample size n] |
||||||||
| EWAS164 | hsa00061 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Fatty acid biosynthesis | 13 | 13 | 0 |
| EWAS164 | hsa00062 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Fatty acid elongation | 25 | 25 | 0 |
| EWAS164 | hsa00072 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Synthesis and degradation of ketone bodies | 10 | 10 | 0 |
| EWAS164 | hsa00220 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Arginine biosynthesis | 20 | 20 | 0 |
| EWAS164 | hsa00430 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Taurine and hypotaurine metabolism | 11 | 11 | 0 |
| EWAS164 | hsa00480 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Glutathione metabolism | 51 | 51 | 0 |
| EWAS164 | hsa00511 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Other glycan degradation | 18 | 18 | 0 |
| EWAS164 | hsa00514 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Other types of O-glycan biosynthesis | 30 | 30 | 0 |
| EWAS164 | hsa00531 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Glycosaminoglycan degradation | 19 | 19 | 0 |
| EWAS164 | hsa00532 | disease | pediatric acute lymphoblastic leukemia [n=765] |
immunophenotype:BCP-ALL(the B-cell precursor ALL) [n=664] |
immunophenotype:T-ALL [n=101] |
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 20 | 20 | 0 |